Please use this identifier to cite or link to this item:
The role of Tel2 in mTOR-mediated cardiac function
|Yorichika_Naaiko_r.pdf||Version for non-UH users. Copying/Printing is not permitted||3.15 MB||Adobe PDF||View/Open|
|Yorichika_Naaiko_uh.pdf||Version for UH users||3.14 MB||Adobe PDF||View/Open|
|Title:||The role of Tel2 in mTOR-mediated cardiac function|
Ischemia reperfusion injury
|Issue Date:||Dec 2013|
|Publisher:||[Honolulu] : [University of Hawaii at Manoa], [December 2013]|
|Abstract:||Previously we showed that the expression of the mechanistic target of rapamycin (mTOR) increases in heart failure, and the cardiac mTOR is sufficient to protect the heart against ischemic stresses.|
Recent studies demonstrated that telomere maintenance 2 (Tel2) stabilizes mTOR in other tissues. In this study, we examined whether Tel2 is sufficient to stabilize cardiac mTOR and prevent cell death against hypoxia. Overexpression of Tel2 in cardiomyocytes (CMs) increases mTOR and activates both mTORC1 and mTORC2. Overexpression of Tel2 protects CM against hypoxia. Gene silencing by siRNA targeting Tel2 showed that Tel2 is necessary for stabilizing mTOR in cardiomyocytes.
We assessed cell shortening and Ca2+ transients as indicators of cardiac function. Preliminary studies of Tel2-overexpressed mTOR-Tg suggest that Tel2 positively regulates contraction and Ca2+ transients via stabilization of mTOR.
A study of Tel2-mediated mTOR activation would provide a novel therapeutic target for a therapy of heart failure.
|Description:||M.S. University of Hawaii at Manoa 2013.|
Includes bibliographical references.
|Appears in Collections:||M.S. - Molecular Biosciences and Bioengineering|
Items in ScholarSpace are protected by copyright, with all rights reserved, unless otherwise indicated.